Press Releases
[New York, NY – September 16, 2025] – Nouveau Biosciences, a biotechnology company pioneering nanomedicine and targeted oncology therapeutics, today announced the appointment of Joseph Turgeon as Chief Operating Officer. Mr. Turgeon brings more than 38 years of experience in the pharmaceutical and biotechnology industries, with a career distinguished by leadership in oncology drug development, […]
[New York, NY – September 16, 2025] – Nouveau Biosciences, a biotechnology company pioneering next-generation nanomedicine and targeted oncology therapeutics, today announced the appointment of Keith M. McGahan as Chief Legal Officer. Mr. McGahan brings more than two decades of executive leadership experience across the healthcare, pharmaceutical, and life sciences sectors, with a distinguished track […]
